COc1ccc(C2C([N+](=O)[O-])=C(N)Oc3c2c(=O)oc2ccccc32)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?